anmelden
SXI Life Sciences
7.772,36
PKT
-3,32
PKT
-0,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 27.12.11 | Novartis kaufen | Raiffeisen Centrobank AG | |
| 23.12.11 | Novartis neutral | Goldman Sachs Group Inc. | |
| 22.12.11 | BB Biotech halten | Hamburger Sparkasse AG (Haspa) | |
| 21.12.11 | Novartis overweight | J.P. Morgan Cazenove | |
| 21.12.11 | Novartis hold | Vontobel Research | |
| 16.12.11 | Novartis outperform | Credit Suisse Group | |
| 15.12.11 | Novartis hold | Vontobel Research | |
| 14.12.11 | Novartis overweight | J.P. Morgan Cazenove | |
| 13.12.11 | Novartis buy | WestLB AG | |
| 13.12.11 | Novartis hold | Vontobel Research | |
| 13.12.11 | Novartis outperform | Credit Suisse Group | |
| 08.12.11 | Novartis hold | Vontobel Research | |
| 06.12.11 | BB Biotech kaufen | Independent Research GmbH | |
| 06.12.11 | Novartis hold | Vontobel Research | |
| 05.12.11 | Straumann hold | Vontobel Research | |
| 02.12.11 | Tecan (N) hold | Vontobel Research | |
| 01.12.11 | Novartis neutral | Citigroup Corp. | |
| 29.11.11 | Novartis underperform | Cheuvreux SA | |
| 28.11.11 | Novartis hold | Vontobel Research | |
| 25.11.11 | Tecan (N) hold | Vontobel Research | |
| 17.11.11 | Novartis hold | Vontobel Research | |
| 15.11.11 | Sonova buy | Vontobel Research | |
| 03.11.11 | Novartis buy | Deutsche Bank AG | |
| 28.10.11 | Lonza neutral | Citigroup Corp. | |
| 28.10.11 | Novartis neutral | Goldman Sachs Group Inc. | |
| 28.10.11 | Newron PharmaceuticalsAz. hold | Vontobel Research | |
| 28.10.11 | Lonza hold | Vontobel Research | |
| 27.10.11 | Novartis buy | Nomura | |
| 27.10.11 | BB Biotech buy | Close Brothers Seydler Research AG | |
| 27.10.11 | Novartis buy | Citigroup Corp. | |
| 26.10.11 | Novartis outperform | Credit Suisse Group | |
| 26.10.11 | Novartis neutral | Exane-BNP Paribas SA | |
| 26.10.11 | Novartis halten | Independent Research GmbH | |
| 26.10.11 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) | |
| 25.10.11 | Straumann buy | Nomura | |
| 25.10.11 | Straumann hold | Vontobel Research | |
| 25.10.11 | Sonova buy | Vontobel Research | |
| 25.10.11 | Novartis hold | Vontobel Research | |
| 24.10.11 | Novartis hold | Vontobel Research | |
| 21.10.11 | Straumann sell | Citigroup Corp. |